Removing a single protein from cells that surround tumours can improve the sensitivity of certain cancers to immunotherapy, researchers have found.

World-leading cancer researchers announce plans to create a new generation of treatments that target the ecosystems supporting cancer. Their new strategy sees cancer genetics and evolution within complex ecosystems as keys to creating new targeted drugs and immunotherapies. They aim to double survival for people with advanced cancer within a decade by combining existing treatments and using smart dosing strategies

Researchers perform a deep dive into the different immune markers within tumour tissue and blood samples of early breast cancer patients whose cancer failed to respond to chemotherapy given to them prior to surgery - the findings could help tailor pre-surgical treatment.